ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
Dow Jones
39.512,84
0,32%
Euro vs US Dollar
1,07875
0,00%
Bitcoin
61.026,23
0,37%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Corbus Pharmaceuticals Holdings Inc (CRBP)

  7. Corbus Pharmaceuticals Holdings Inc (CRBP) News

CRBP

Corbus Pharmaceuticals (CRBP)

Corbus Pharmaceuticals Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CRBP
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/05/202422h03Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/05/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/05/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/02/202423h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422h45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422h41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202422h08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/02/202421h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
06/02/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/02/202422h47Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/02/202422h21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
05/02/202414h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/02/202423h27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
01/02/202423h09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
31/01/202415h16Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
30/01/202422h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202422h40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202413h31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
29/01/202413h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
26/01/202413h47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
09/01/202414h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
13/11/202323h25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/11/202322h57Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
07/11/202315h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/08/202323h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
08/08/202315h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
03/08/202314h44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
14/06/202312h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRBPCorbus Pharmaceuticals Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRBP

Kürzlich von Ihnen besucht

TG
DBK
Deutsche Bank
TG
DTE
Deutsche Telekom
TG
RHM
Rheinmetall
FX
EURUSD
Euro vs US Dollar
TG
BAS
BASF
NASDAQ
NVDA
NVIDIA
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
COIN
BTCUSD
Bitcoin
PM
XAUUSD
Gold vs US Dollar
TG
BAYN
Bayer
CCOM
US100
US Tech 100
TG
ALV
Allianz
TG
MBG
MercedesBenz
TG
D7G
Nel ASA
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten